Published by Benjamin Chiou on 18th September 2023
(Sharecast News) - Shares in biopharma group Hemogenyx surged on Monday after the company received a $0.83m investment from Prevail Partners as it continues to work on its planned clinical trial for leukaemia treatment.
URL: http://www.digitallook.com/dl/news/story/33776332/...